Bookmark and Share

Compound Summary for: CID 11954293

Sycrest

Also known as: SureCN6029138, DB06216
Molecular Formula: C21H20ClNO5   Molecular Weight: 401.8402   InChIKey: GMDCDXMAFMEDAG-BTJKTKAUSA-N
Developed by Schering-Plough after its merger with Organon International, asenapine is a sublingually administered, atypical antipsychotic for treatment of schizophrenia and acute mania associated with bipolar disorder. Asenapine also belongs to the dibenzo-oxepino pyrrole class. It is also for severe post-traumatic stress disorder nightmares in soldiers as an off-label use. FDA approved on August 13, 2009.    From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Literature
Biomolecular Interactions and Pathways
Classification
Chemical and Physical Properties
_ _